This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Cambridge. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Paul Glossop: Innovator in Pharmaceutical Chemistry
Introduction
Paul Glossop is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzo[c][2,6]naphthyridine derivatives.
Latest Patents
Paul Glossop holds a patent for "Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof." This patent includes a compound of the formula: (5-(2-(4-((3,5-difluoro-4-(trifluoromethoxy)benzyl)amino)butoxy)ethoxy)benzo[c][2,6]naphthyridine-8-carboxylic acid) or a pharmaceutically acceptable salt thereof. The patent also covers a pharmaceutical composition comprising the above compound, or a pharmaceutically acceptable salt thereof, along with a pharmaceutically acceptable excipient.
Career Highlights
Paul is associated with Cambridge Enterprise Limited, where he applies his expertise in developing innovative pharmaceutical solutions. His work has been instrumental in advancing therapeutic applications in the medical field.
Collaborations
Paul Glossop has collaborated with notable professionals in his field, including Marko Juhana Hyvonen and Paul Brear. These collaborations have contributed to the success of his projects and innovations.
Conclusion
Paul Glossop is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions continue to impact the field positively, showcasing the importance of research and development in healthcare.